Pharmacokinetic Evaluation of Empagliflozin

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 2, 2017

Primary Completion Date

February 2, 2017

Study Completion Date

February 2, 2017

Conditions
Diabetes Mellitus
Interventions
DRUG

Empagliflozin 25mg

Samples from six, healthy, adult, male, smoking, Egyptian volunteers (age: 22-33 years, Average weight: 77.8 kg, Average BMI: 29.2) will be collected at 0, 0.5, 1, 1.5, 2, 3, 4, 8 and 12 h after administration of Empagliflozin 25 mg

All Listed Sponsors
lead

British University In Egypt

OTHER

NCT03059056 - Pharmacokinetic Evaluation of Empagliflozin | Biotech Hunter | Biotech Hunter